Le Lézard
Classified in: Health
Subject: SVY

The global malaria diagnostics market size is projected to reach USD 998.85 million by 2026 expanding at a CAGR of 5.4%


NEW YORK, Oct. 21, 2019 /PRNewswire/ -- Malaria Diagnostics Market Size, Share & Trends Analysis Report By Technology (RDTs, Microscopy, Molecular Diagnostic Tests), By Region (Eastern Mediterranean, Southeast Asia, Africa), And Segment Forecasts, 2019 - 2026

Download the full report: https://www.reportbuyer.com/product/5807247/?utm_source=PRN

The global malaria diagnostics market size is projected to reach USD 998.85 million by 2026 expanding at a CAGR of 5.4%. Rising prevalence of the tropical disease in endemic countries, development of novel diagnostic techniques, and rising investments by regional governments and private investors are expected to propel market growth. Malaria is one of the most widespread life-threatening diseases, commonly occurring in the tropical and subtropical regions due to changing climate, low economic growth, underdeveloped healthcare infrastructure, and lack of access to advanced treatment.

Increasing number of government initiatives and investments by market participants are also anticipated to fuel market growth in the near future.A large number of malarial elimination programs are being undertaken by major companies to reduce the disease prevalence.

For instance, Novartis's Malaria Initiative was aimed at facilitating malaria elimination and control.Along with various organizations, the company has provided non-profit treatment to 750 million people across 60 countries. Thus, such initiatives are anticipated to facilitate the development of novel technologies and aid in market penetration.

Further key findings from the study suggest:
? Conventional usage of microscopic examination for detection of malarial parasite has driven the microscopy technology segment
? RDTs are anticipated to account for the largest revenue share owing to ease of usage, convenience, and rapid diagnosis
? Molecular diagnostic tests is projected to be the fastest-growing technology segment during the forecast period owing to their accuracy and capability of detecting low parasite count
? Africa led the malaria diagnostics market in 2018 due to high disease incidence and increased adoption of various malarial diagnostic techniques in the region
? Southeast Asia also held a considerable revenue share in 2018 owing to high disease reoccurrence and initiatives undertaken to curb malarial incidence
? Few key companies include Access Bio, Inc.; Alere, Inc.; Premier Medical Corporation Ltd.; Sysmex Partec GmbH; bioMérieux, Beckman Coulter, Inc.; Siemens Healthcare; and Leica Microsystems

Download the full report: https://www.reportbuyer.com/product/5807247/?utm_source=PRN

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: